Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin

被引：48

作者：

Nakad, A

Bataille, L

Hamoir, V

Sempoux, C

Horsmans, Y ^{[3
]}

机构：

[1] Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium

[2] Univ Catholique Louvain, Clin Univ St Luc, Dept Gastroenterol, B-1200 Brussels, Belgium

[3] Clin Notre Dame, Dept Internal Med, Tournai, Belgium

来源：

关键词：

D O I：

10.1016/S0140-6736(99)00569-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1763 / 1764

页数：2

共 5 条

[1] Ballare M, 1992, Minerva Gastroenterol Dietol, V38, P41
[2] An overview of the clinical safety profile of atorvastatin (Lipitor), a new HMG-CoA reductase inhibitor
Black, DM
Bakker-Arkema, RG
Nawrocki, JW
[J]. ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (06) : 577 - 584
[3] Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors
Desager, JP
Horsmans, Y
[J]. CLINICAL PHARMACOKINETICS, 1996, 31 (05) : 348 - 371
[4] KOCAREK TA, 1995, DRUG METAB DISPOS, V23, P415
[5] KOOMSTRA JJ, 1996, NED TIJDSCHR GENEESK, V140, P846